0
2015
Asia-pacific Anti-inflammatory Therapeutics Market

Asia-Pacific Anti-Inflammatory Therapeutics Market

by Indication [Arthritis, Respiratory Disease, Multiple Sclerosis, Psoriasis, and Inflammatory Bowel Disease (IBD)], by Drug Class [Nonsteroidal Anti-Inflammatory Diseases (NSAIDs), Corticosteroids, Biologics, and Immune Selective Anti-Inflammatory Derivatives (ImSAIDs)]: Asia-Pacific Opportunity Analysis and Industry Forecast, 2015-2020
Update Available On-Demand

Report Code: A01012
Pages: 130
Jun 2015 | 10660 Views
Author(s) : Garima C
Tables: 26
Charts: 36
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Asia-pacific Anti-inflammatory Therapeutics Market

Request Now !

Asia-pacific Anti-Inflammatory Therapeutics Market Overview:

Asia-pacific Anti-Inflammatory Therapeutics Market was valued at $14,863.8 million in 2014, and is estimated to reach $24,542.4 million by 2020, growing at a CAGR of 8.6% during the study period. Anti-inflammatory drugs or therapeutics are used to alleviate mild or chronic pain which may arise due to headaches, rheumatic arthritis, and sprains,. The examples of some anti-inflammatory drugs include aspirin, acelofenac, celecoxib, etoricoxib, acemetacin, etodolac, ibuprofen, and meloxicam. Rise in number of autoimmune and respiratory diseases, new drugs in development pipeline and increased usage of OTC NSAIDs are expected to drive the market growth. Moreover, increasing awareness of anti-inflammatory biologics and favorable government initiatives in the Asia-Pacific region are expected to drive the market during the analysis period. However, factors, such as side effects of anti-inflammatory drugs and uncertain patent legislations, e.g., compulsory licensing in India would continue to impede the market growth.

Rise in Incidence of Auto-immune and Respiratory Conditions

Rising incidences of chronic inflammatory and autoimmune diseases has increased the need of anti-inflammatory therapeutics. Anti-inflammatory drugs are used in various conditions such as arthritis, multiple sclerosis, psoriasis, asthma, COPD, inflammatory bowel disease and other inflammatory diseases. According to the Arthritis Foundation of North Eastern New York, arthritis is the leading cause of disability in the U.S. and 1 out of 5 Americans is affected by arthritis, with majority of the cases seen in women. According to the World Health Organization, about 3 million people died due to COPD in year 2012, which is equal to 6% of total global deaths that year.

Asia-Pacific-Anti-Inflammatory-Therapeutics-Market,-2015-2020

Innovation in Treatment

Large number of drugs are in various phases of drug development and are expected to enter the market in near future. These drugs generally have a better efficacy and lesser side effects compared to the existing product range. Thus, these companies would be able to generate higher revenues than the older drugs and also drive the market growth. For instance, Amgen has 8 anti-inflammatory compounds in the drug development pipeline. The compounds AMG 282, AMG 357, AMG 557 and AMG 811 are in the first phase of the drug development. The compounds AMG 139, AMG 157 and AMG 181 are in the second phase of the drug development and the compound brodalumab is in third phase of the drug development.

The Asia-Pacific anti-inflammatory therapeutics market is segmented on the basis of indication, drug class and country. On the basis of indication, the market is divided into arthritis, respiratory disease, multiple sclerosis, psoriasis, and inflammatory bowel disease (IBD) and others. On the basis of drug class, the market is segmented into anti-inflammatory biologics, non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. Geographically, the market is segmented into six countries namely Japan, China, India, Australia, South Korea, Indonesia and others.

The key companies operating in the market include Pfizer Inc., AbbVie Inc., Johnson & Johnson, GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, F. Hoffmann-La Roche AG, Eli Lily and Company, AstraZeneca PLC and Amgen Inc.

Key Benefits

  • The study provides an in-depth analysis of the Asia-Pacific anti-inflammatory therapeutics market, with current trends and future estimations, to elucidate the imminent investment pockets.
  • Quantitative analysis from 2014 to 2020 is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Comprehensive analysis of countries of the Asia-Pacific region is provided to determine the prevailing opportunities.
  • Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.

Asia-pacific Anti-Inflammatory Therapeutics Market Key Segments:

By Indication

  • Arthritis
    • Rheumatoid Arthritis
    • Osteoarthritis
    • Ankylosing Spondylitis
    • Psoriatic Arthritis
    • Gout
  • Respiratory Disease
    • Asthma
    • Chronic Obstructive Pulmonary Diseases (COPD)
  • Multiple Sclerosis
  • Psoriasis
  • Inflammatory Bowel Disease (IBD)
    • Crohn’s disease
    • Ulcerative Colitis
  • Other Inflammatory disease

By Drug Class

  • Nonsteroidal Anti-Inflammatory Diseases (NSAIDs)
  • Corticosteroids
  • Biologics
  • Immune Selective Anti-Inflammatory Derivatives (ImSAIDs)

By Country

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
  • Other APAC countries
 

Loading Table Of Content...


 
 
PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample

Purchase Full Report of
Asia-pacific Anti-inflammatory Therapeutics Market

Start reading instantly.
This Report and over 19,320+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $2,573
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Jun 2016 - Jun 2017)
  • Data Pack
  • $2,859
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2016 - Jun 2017)
  • Single User
  • $3,999
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2016 - Jun 2017)
  • Five Users
  • $4,803
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2016 - Jun 2017)
  • Enterprise
    License/PDF

  • $7,698
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2016 - Jun 2017)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers